){kind=logo}
)
)
)
)
AgNavigator News
-
PepsiCo nears the halfway point of its 2030 goal to support regenerative and restorative practices on 10 million acres.
-
Rovensa Next has joined the €6.4 million Horizon Europe BIO² project, which brings together research and industry partners to develop circular, bio-based fertilisers and microbial solutions for agriculture. The project aims to create at least two fully circular biofertilisers and additional biocontrol and animal health products by 2029, with real-world testing across several European countries to validate their effectiveness and sustainability. This initiative aligns with EU goals to reduce reliance on conventional chemical inputs and promote resource-efficient farming, using data-driven agronomy and integrated biological solutions. Separately, Rovensa Next will distribute Novonesis biosolutions in the U.S. from 2027, further expanding its presence in the growing biologicals market.
-
Syngenta Group has appointed Hengde Qin as its next CEO, effective August 2026, signaling a focus on operational continuity and financial discipline as it pursues a long-anticipated Hong Kong IPO. Qin, currently COO and head of seeds, brings extensive experience in finance, operations, and Asian capital markets, aligning with the company’s strategic priorities. His leadership highlights Syngenta’s commitment to innovation, sustainability, and integrated, tech-driven farming solutions, while reinforcing its ties to Chinese ownership and investors. The move positions Syngenta for execution and investor readiness amid shifting market conditions and geopolitical scrutiny.
-
The UK faces a strategic decision following the EU’s adoption of new genomic techniques (NGTs) rules: maintain its early, more permissive regulatory lead on gene editing or align with Europe to secure trade advantages. While supporters argue the UK’s flexible framework could attract innovation, delays in implementation risk eroding its first-mover advantage. Opponents warn that divergence may introduce trade barriers, urging regulatory alignment to enable market access and certainty. As the EU moves toward its own NGT regime, the UK’s choice between speed, flexibility, and integration will shape its future role in agricultural biotechnology.
)
)
)
)
)
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)